Drug – bio-affecting and body treating compositions – In vivo diagnosis or in vivo testing – X-ray contrast imaging agent
Reexamination Certificate
2007-10-31
2011-12-27
Jones, D L (Department: 1618)
Drug, bio-affecting and body treating compositions
In vivo diagnosis or in vivo testing
X-ray contrast imaging agent
C424S001110, C424S001650, C424S001810, C424S001850, C424S001890, C424S009100, C424S009400, C424S009440
Reexamination Certificate
active
08084018
ABSTRACT:
Presented is a method for assessing dopamine transporter levels in a selected area of a subject's central nervous system by SPECT imaging comprising administering an injection of a labeled dopamine transporter ligand at approximately the time the subject is positioned for SPECT imaging and initiating a SPECT acquisition for a duration of about 30 minutes commencing at about 15 minutes after administration of labeled dopamine transporter ligand; and assessing, based on said SPECT acquisition, the amount of labeled dopamine transporter ligand that is bound to dopamine transporter.
REFERENCES:
patent: 5493026 (1996-02-01), Elmaleh et al.
patent: 5506359 (1996-04-01), Madras et al.
patent: 5770180 (1998-06-01), Madras et al.
patent: 5853696 (1998-12-01), Elmaleh et al.
patent: 5948933 (1999-09-01), Meltzer et al.
patent: 6171576 (2001-01-01), Meltzer et al.
patent: 6548041 (2003-04-01), Meltzer et al.
patent: 7081238 (2006-07-01), Madras et al.
patent: 2002/0150535 (2002-10-01), Madras et al.
patent: 2006/0257316 (2006-11-01), Madras et al.
patent: 2010/0143248 (2010-06-01), Madras et al.
Seibyl J, et al., Iodine-123-β-CIT and Iodine-123-FPCIT SPECT Measurement of Dopamine Transporters in Healthy Subjects and Parkinson's Patients,J. Nucl. Med. 39;1500-08, 1998.
Marek K. et al., A molecular map for neurodegeneration,Science289: 409-11, 2000.
Seibyl J. et al., Decreased SPECT [123-I]β-CIT striatal uptake correlates with symptom severity in Parkinson's disease,American Neurological Association, 38:589-98, 1995.
Seibyl J. et al., Test/retest reproducibility of Iodine-I23-βCIT SPECT brain measurement of dopamine transporters in Parkinson's patients,J. Nucl. Med.38:1453-59, 1997.
Laruelle M. et al., Graphical, kinetic, and equilibrium analyses of in vivo [123I]β-CIT binding to dopamine transporters in healthy human subjects.,J. Cereb. Blood Flow Metab.14:982-94, 1994.
Kugaya, A., et al., Changes in human in vivo serotonin and dopamine transporter availabilities during chronic antidepressant administration,Neuropsychopharmacology, 28(2).413-20, 2003.
Sahani, D., et al., Quantitative measurements of medical images for pharmaceutical clinical trials: comparison between on-site and off-site assessments,AJR Am J Roentgenol. 2000. 174(4): 1159-62.
Fischman, A.J., et al., Rapid detection of Parkinson's disease by SPECT with altropane: a selective ligand for dopamine transporters,Synapse, 1998, 29(2): 128-41.
Madras, B.K., et al., Altropane, a SPECT or PET imaging probe for dopamine neurons: III. Human dopamine transporter in postmortem normal and Parkinson's diseased brain,Synapse, 1998. 29(2):116-27.
Madras, B.K., et al., Altropane, a SPECT or PET imaging probe for dopamine neurons: II. Distribution to dopamine-rich regions of primate brain,Synapse, 1998, 29(2):105-15.
Madras, B.K., et al., Altropane, a SPECT or PET imaging probe for dopamine neurons: I. Dopamine transporter binding in primate brain,Synapse, 1998. 29(2):93-104.
Fischman, A.J., et al., SPECT imaging of dopamine transporter sites in normal and MPTP-Treated rhesus monkeys,J Nucl Med, 38(1):144-50.
Madras, B.K., et al., Technepine: A high-affinity99mTechnetium probe to label the dopamine transporter in brain by SPECT imaging,Synapse, 1996. 22:239-46.
Farde, L, et al., Kinetic analysis of central [11C] raclopride binding to D2-Dopamine receptors studied by PET—a comparison to the equilibrium analysis,J. Cereb. Blood Flow Metab., 1989, 9:696-08.
Meltzer, P.C., et al., Substituted 3-phenyltropane analogs of cocaine: synthesis, inhibition on binging at cocaine recognition sites, and positron emission tomography imaging, 1993,J. Med, Chem,, 36:855-62.
Milius, R.A., et al., Synthesis and receptor binding of N-substituted tropane derivative. High-affinity ligands for the cocaine receptor, 1991,J. Med. Chem., 34, 1728-31.
Alseres Pharmaceuticals, Inc.
Jones D L
Rissman Hendricks & Oliverio LLP
LandOfFree
Methods for imaging dopamine transporter level does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for imaging dopamine transporter level, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for imaging dopamine transporter level will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4313879